Filters
Other countries
Results: 1 to 16 of 16
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
OncoFISH of NHL diffuse large cells (t(14;18), t(8;14) and BCL6) CGC Genetics Unilabs Portugal | 1 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 146 | 18 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 95 | 71 |
|
Ambry Genetics United States | 146 | 91 |
|
PreventionGenetics, part of Exact Sciences United States | 32 | 25 |
|
PreventionGenetics, part of Exact Sciences United States | 122 | 117 |
|
KRAS- Mutation detection by sanger Functional Genomic Platform Centre National pour la Recherche Scientifique et Technique Morocco | 1 | 1 |
|
BRAF extended mutation Analysis Integrated Oncology- Phoenix United States | 14 | 1 |
|
Colorectal Cancer Comprehensive Panel Fulgent Genetics United States | 77 | 22 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 16 of 16
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.